Status:
COMPLETED
Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Systemic Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Systemic sclerosis is an autoimmune disease characterized by skin lesions and visceral responsible for significant morbidity. Microcirculatory disorders and tissue fibrosis are excessive severity of t...
Eligibility Criteria
Inclusion
- Men and women of more than 18 years old wishing a therapeutic alternative.
- Functional Disability of the hand authenticated by a functional index of the hand of Cochin upper to 20.
Exclusion
- Persons participating simultaneously in another biomedical search(research)
- Minors
- Pregnant or breast-feeding Women
- Major Persons protected by the law (under guardianship or guardianship)
- Persons staying in a sanitary or social establishment
- Persons in emergency situation
- Private persons of freedom
Key Trial Info
Start Date :
November 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01813279
Start Date
November 1 2012
End Date
March 1 2014
Last Update
September 1 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hopitaux de Marseille
Marseille, France, 13354